These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 5493526)

  • 1. Suppression of antibodies to nucleic acids with polyinosinic-polycytidylic acid and cyclophosphamide in murine lupus.
    Steinberg AD; Talal N
    Clin Exp Immunol; 1970 Nov; 7(5):687-91. PubMed ID: 5493526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclophosphamide treatment of mouse systemic lupus erythematosus.
    Horowitz RE; Dubois EL; Weiner J; Strain L
    Lab Invest; 1969 Sep; 21(3):199-206. PubMed ID: 4185855
    [No Abstract]   [Full Text] [Related]  

  • 3. Specific immunosuppression, polyinosinic--polycytidylic acid, and viruses in New Zealand mice.
    Talal N; Steinberg AD; Gazdar AF
    Fed Proc; 1971; 30(6):1842-5. PubMed ID: 4330992
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune cell cooperation, viruses, and antibodies to nucleic acids in New Zealand mice.
    Talal N; Steinberg AD; Jacobs ME; Chused TM; Gazdar AF
    J Exp Med; 1971 Sep; 134(3 Pt 2):52s-64s. PubMed ID: 5570756
    [No Abstract]   [Full Text] [Related]  

  • 5. The New Zealand mouse as a model for the therapy of human SLE: immunomodulation of murine lupus by sex hormones and cyclophosphamide.
    Papoian R; Roubinian JR; Dauphinée MJ; Talal N
    Agents Actions Suppl; 1980; 7():41-5. PubMed ID: 6941685
    [No Abstract]   [Full Text] [Related]  

  • 6. Tolerance to polyinosinic-polycytidylic acid in NZB-NZW mice.
    Steinberg AD; Daley GG; Talal N
    Science; 1970 Feb; 167(3919):870-1. PubMed ID: 5410848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term administration of cyclophosphamide in MRL/1 mice. I. The effects on the development of immunological abnormalities and lupus nephritis.
    Shiraki M; Fujiwara M; Tomura S
    Clin Exp Immunol; 1984 Feb; 55(2):333-9. PubMed ID: 6607792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory T cells and systemic lupus erythematosus.
    Mudd PA; Teague BN; Farris AD
    Scand J Immunol; 2006 Sep; 64(3):211-8. PubMed ID: 16918689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental approach to the treatment of systemic lupus erythematosus].
    Lambert PH; Miescher PA
    Ther Umsch; 1971 Sep; 28(9):573-8. PubMed ID: 5315892
    [No Abstract]   [Full Text] [Related]  

  • 10. The pathogenesis of autoimmunity in New Zealand mice. II. Acceleration of glomerulonephritis by polyinosinic-polycytidylic acid.
    Carpenter DF; Steinberg AD; Schur PH; Talal N
    Lab Invest; 1970 Dec; 23(6):628-34. PubMed ID: 5312472
    [No Abstract]   [Full Text] [Related]  

  • 11. Normal induction and maintenance of tolerance in (NZBxNZW) F1 mice.
    Russell AS; Denman AM
    Clin Exp Immunol; 1969 Sep; 5(3):265-72. PubMed ID: 5810151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The immunosuppressive agents. 3. The immunosuppressive agents in hematology].
    Meshaka G; Jacquillat C; Sultan Y
    Presse Med (1893); 1967 Jul; 75(32):1653-5. PubMed ID: 6067478
    [No Abstract]   [Full Text] [Related]  

  • 13. Nucleic acid recognition receptors in autoimmunity.
    Krug A
    Handb Exp Pharmacol; 2008; (183):129-51. PubMed ID: 18071658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The intervention of hereditary factors in human acute diffuse lupus erythematosus and their equivalents in animals].
    Thivolet J; Monier JC; Ruel JP; Beyvin AJ
    Ann Biol Clin (Paris); 1966; 24(10):1163-9. PubMed ID: 5299135
    [No Abstract]   [Full Text] [Related]  

  • 15. The pathogenesis of autoimmunity in New Zealand mice. 3. Factors influencing the formation of anti-nucleic acid antibodies.
    Steinberg AD; Pincus T; Talal N
    Immunology; 1971 Apr; 20(4):523-31. PubMed ID: 5553068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathogenesis of autoimmunity in New Zealand mice, I. Induction of antinucleic acid antibodies by polyinosinic-polycytidylic acid.
    Steinberg AD; Baron S; Talal N
    Proc Natl Acad Sci U S A; 1969 Aug; 63(4):1102-7. PubMed ID: 5307809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trials with cyclophosphamide in systemic lupus erythematosus.
    Sato FF
    Am J Nurs; 1972 Jun; 72(6):1077-9. PubMed ID: 4481770
    [No Abstract]   [Full Text] [Related]  

  • 18. Nucleic acids in the spleen, kidney and liver of the female (NZBxNZW) F1 hybrid mouse.
    Gabriel R
    J Pathol; 1972 Feb; 106(2):127-31. PubMed ID: 4537597
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe gastrointestinal involvement in systemic lupus erythematosus treated with rituximab and cyclophosphamide (B-cell depletion therapy).
    Waite L; Morrison E
    Lupus; 2007; 16(10):841-2. PubMed ID: 17895311
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential effects of 6-mercaptopurine and cyclophosphamide on autoimmune phenomena in NZB mice.
    Lemmel E; Hurd ER; Ziff M
    Clin Exp Immunol; 1971 Feb; 8(2):355-62. PubMed ID: 4102260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.